Insider · CIK 0001225198

VAN NOSTRAND ROBERT L

Reports to the SEC for 7 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001225198

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-07	SLSSELLAS Life Sciences Group, Inc.A Award	Director	AAward	+50K sh	—	—	82,900
2025-06-12	SLSSELLAS Life Sciences Group, Inc.P Purchase	Director	PPurchase	+10K sh	$1.48	+$14.8K	20,400
2025-04-02	Intra-Cellular Therapies, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−11.3K sh	$132.00	−$1.5M	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.8K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,009 sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,322 sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−2,951 sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2025-01-10	SLSSELLAS Life Sciences Group, Inc.A Award	Director	AAward	+12.5K sh	—	—	22,900
2025-01-10	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.5K sh	—	—	18,500
2024-06-28	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+83 sh	$68.49	+$5,684.67	11,340
2024-06-23	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,567 sh	—	—	0
2024-06-23	Intra-Cellular Therapies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,567 sh	—	—	11,257
2024-06-18	Intra-Cellular Therapies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$16.86	+$337K	29,690
2024-06-18	Intra-Cellular Therapies, Inc.S Sale	Director	SSale	−8,891 sh	$75.71	−$673K	20,799
2024-06-18	Intra-Cellular Therapies, Inc.S Sale	Director	SSale	−11.1K sh	$76.07	−$845K	9,690
2024-06-18	Intra-Cellular Therapies, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2024-06-14	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	Director	AAward	+2,951 sh	—	—	2,951
2024-06-14	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	Director	AAward	+4,322 sh	—	—	4,322
2024-03-31	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+79 sh	$69.20	+$5,466.8	9,690
2024-03-28	YIELD10 BIOSCIENCE, INC.A Award	Director	AAward	+11.9K sh	—	—	48,635
2024-02-27	Intra-Cellular Therapies, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2024-02-27	Intra-Cellular Therapies, Inc.S Sale	Director	SSale	−10.3K sh	$73.14	−$757K	9,611
2024-02-27	Intra-Cellular Therapies, Inc.S Sale	Director	SSale	−9,651 sh	$72.71	−$702K	19,960
2024-02-27	Intra-Cellular Therapies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$18.56	+$371K	29,611
2024-01-22	SLSSELLAS Life Sciences Group, Inc.A Award	Director	AAward	+6,000 sh	—	—	10,400
2024-01-22	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-12-31	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+76 sh	$71.62	+$5,443.12	9,611
2023-12-29	YIELD10 BIOSCIENCE, INC.A Award	Director	AAward	+18.9K sh	—	—	36,711
2023-09-30	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+105 sh	$52.09	+$5,469.45	9,535
2023-09-29	YIELD10 BIOSCIENCE, INC.A Award	Director	AAward	+13.9K sh	—	—	17,832
2023-06-30	YIELD10 BIOSCIENCE, INC.A Award	Director	AAward	+2,040 sh	—	—	3,964
2023-06-30	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+85 sh	$63.32	+$5,382.2	9,430
2023-06-23	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	Director	AAward	+7,009 sh	—	—	7,009
2023-06-23	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	Director	AAward	+1,567 sh	—	—	1,567
2023-05-25	YIELD10 BIOSCIENCE, INC.Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2023-04-17	Intra-Cellular Therapies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$13.05	+$131K	19,345
2023-04-17	Intra-Cellular Therapies, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2023-04-17	Intra-Cellular Therapies, Inc.S Sale	Director	SSale	−10K sh	$63.00	−$630K	9,345
2023-03-31	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+95 sh	$54.15	+$5,144.25	9,345
2023-03-31	YIELD10 BIOSCIENCE, INC.A Award	Director	AAward	+1,642 sh	—	—	1,924
2023-02-02	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,500 sh	—	—	9,500
2023-02-02	SLSSELLAS Life Sciences Group, Inc.A Award	Director	AAward	+2,500 sh	—	—	4,400
2022-12-31	YIELD10 BIOSCIENCE, INC.Stock Option (right to buy)A Award	Director	AAward	+2,109 sh	$1.58	+$3,332.22	2,109
2022-12-30	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+97 sh	$52.92	+$5,133.24	9,250
2022-09-30	YIELD10 BIOSCIENCE, INC.Stock Option (right to buy)A Award	Director	AAward	+1,601 sh	$2.83	+$4,530.83	1,601

Recent filings

Accepted (ET)
Jan 94
VAN NOSTRAND ROBERT L0001104659-26-002511
SEC(opens sec.gov)
Jun 134
VAN NOSTRAND ROBERT L0001104659-25-059166
SEC(opens sec.gov)
Apr 24
VAN NOSTRAND ROBERT L0000950170-25-049636
SEC(opens sec.gov)
Jan 144
VAN NOSTRAND ROBERT L0001104659-25-003497
SEC(opens sec.gov)
Jul 24
VAN NOSTRAND ROBERT L0000950170-24-080987
SEC(opens sec.gov)
Jun 254
VAN NOSTRAND ROBERT L0000950170-24-077472
SEC(opens sec.gov)
Jun 214
VAN NOSTRAND ROBERT L0000950170-24-076380
SEC(opens sec.gov)

Companies

Address

C/O SELLAS LIFE SCIENCES GROUP, INC., 7 TIMES SQUARE, SUITE 2503

NEW YORK, NY, 10036